GENOTROPIN® How Supplied/Storage and Handling

(somatropin)

16 HOW SUPPLIED/STORAGE AND HANDLING

GENOTROPIN lyophilized powder is available in the following packages:

5 mg two-chamber cartridge (with preservative)

Concentration of 5 mg/mL

For use with the GENOTROPIN PEN® 5 Growth Hormone Delivery Device.

Package of 1NDC 0013-2626-81

12 mg two-chamber cartridge (with preservative)

Concentration of 12 mg/mL

For use with the GENOTROPIN PEN 12 Growth Hormone Delivery Device.

Package of 1NDC 0013-2646-81

GENOTROPIN MINIQUICK Growth Hormone Delivery Device containing a two-chamber cartridge of GENOTROPIN (without preservative)

After reconstitution, each GENOTROPIN MINIQUICK delivers 0.25 mL, regardless of strength. Available in the following strengths, each in a package of 7:

0.2 mgNDC 0013-2649-02
0.4 mgNDC 0013-2650-02
0.6 mgNDC 0013-2651-02
0.8 mgNDC 0013-2652-02
1.0 mgNDC 0013-2653-02
1.2 mgNDC 0013-2654-02
1.4 mgNDC 0013-2655-02
1.6 mgNDC 0013-2656-02
1.8 mgNDC 0013-2657-02
2.0 mgNDC 0013-2658-02

Storage and Handling

Except as noted below, store GENOTROPIN lyophilized powder under refrigeration at 36°F to 46°F (2°C to 8°C).Do not freeze. Protect from light.

The 5 mg and 12 mg cartridges of GENOTROPIN contain a diluent with a preservative. Thus, after reconstitution, they may be stored under refrigeration for up to 28 days.

The GENOTROPIN MINIQUICK Growth Hormone Delivery Device should be refrigerated prior to dispensing, but may be stored at or below 77°F (25°C) for up to three months after dispensing. The diluent has no preservative. After reconstitution, the GENOTROPIN MINIQUICK may be stored under refrigeration for up to 24 hours before use. The GENOTROPIN MINIQUICK should be used only once and then discarded.

Find GENOTROPIN® medical information:

Find GENOTROPIN® medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

GENOTROPIN® Quick Finder

Medication Guide

Health Professional Information

How Supplied/Storage and Handling

16 HOW SUPPLIED/STORAGE AND HANDLING

GENOTROPIN lyophilized powder is available in the following packages:

5 mg two-chamber cartridge (with preservative)

Concentration of 5 mg/mL

For use with the GENOTROPIN PEN® 5 Growth Hormone Delivery Device.

Package of 1NDC 0013-2626-81

12 mg two-chamber cartridge (with preservative)

Concentration of 12 mg/mL

For use with the GENOTROPIN PEN 12 Growth Hormone Delivery Device.

Package of 1NDC 0013-2646-81

GENOTROPIN MINIQUICK Growth Hormone Delivery Device containing a two-chamber cartridge of GENOTROPIN (without preservative)

After reconstitution, each GENOTROPIN MINIQUICK delivers 0.25 mL, regardless of strength. Available in the following strengths, each in a package of 7:

0.2 mgNDC 0013-2649-02
0.4 mgNDC 0013-2650-02
0.6 mgNDC 0013-2651-02
0.8 mgNDC 0013-2652-02
1.0 mgNDC 0013-2653-02
1.2 mgNDC 0013-2654-02
1.4 mgNDC 0013-2655-02
1.6 mgNDC 0013-2656-02
1.8 mgNDC 0013-2657-02
2.0 mgNDC 0013-2658-02

Storage and Handling

Except as noted below, store GENOTROPIN lyophilized powder under refrigeration at 36°F to 46°F (2°C to 8°C).Do not freeze. Protect from light.

The 5 mg and 12 mg cartridges of GENOTROPIN contain a diluent with a preservative. Thus, after reconstitution, they may be stored under refrigeration for up to 28 days.

The GENOTROPIN MINIQUICK Growth Hormone Delivery Device should be refrigerated prior to dispensing, but may be stored at or below 77°F (25°C) for up to three months after dispensing. The diluent has no preservative. After reconstitution, the GENOTROPIN MINIQUICK may be stored under refrigeration for up to 24 hours before use. The GENOTROPIN MINIQUICK should be used only once and then discarded.

Prescribing Information
Download Prescribing Information

Health Professional Information

How Supplied/Storage and Handling

16 HOW SUPPLIED/STORAGE AND HANDLING

GENOTROPIN lyophilized powder is available in the following packages:

5 mg two-chamber cartridge (with preservative)

Concentration of 5 mg/mL

For use with the GENOTROPIN PEN® 5 Growth Hormone Delivery Device.

Package of 1NDC 0013-2626-81

12 mg two-chamber cartridge (with preservative)

Concentration of 12 mg/mL

For use with the GENOTROPIN PEN 12 Growth Hormone Delivery Device.

Package of 1NDC 0013-2646-81

GENOTROPIN MINIQUICK Growth Hormone Delivery Device containing a two-chamber cartridge of GENOTROPIN (without preservative)

After reconstitution, each GENOTROPIN MINIQUICK delivers 0.25 mL, regardless of strength. Available in the following strengths, each in a package of 7:

0.2 mgNDC 0013-2649-02
0.4 mgNDC 0013-2650-02
0.6 mgNDC 0013-2651-02
0.8 mgNDC 0013-2652-02
1.0 mgNDC 0013-2653-02
1.2 mgNDC 0013-2654-02
1.4 mgNDC 0013-2655-02
1.6 mgNDC 0013-2656-02
1.8 mgNDC 0013-2657-02
2.0 mgNDC 0013-2658-02

Storage and Handling

Except as noted below, store GENOTROPIN lyophilized powder under refrigeration at 36°F to 46°F (2°C to 8°C).Do not freeze. Protect from light.

The 5 mg and 12 mg cartridges of GENOTROPIN contain a diluent with a preservative. Thus, after reconstitution, they may be stored under refrigeration for up to 28 days.

The GENOTROPIN MINIQUICK Growth Hormone Delivery Device should be refrigerated prior to dispensing, but may be stored at or below 77°F (25°C) for up to three months after dispensing. The diluent has no preservative. After reconstitution, the GENOTROPIN MINIQUICK may be stored under refrigeration for up to 24 hours before use. The GENOTROPIN MINIQUICK should be used only once and then discarded.

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Contact Medical Information.9AM-5PM ET Monday to Friday; excluding holidays.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.